My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


IPV Infanrix suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)



GlaxoSmithKline (Ireland) LimitedPA1077/108/001

Main Information

Trade NameIPV Infanrix suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
Active SubstancesPertussis toxoid
Filamentous haemagglutinin
Pertactin
Diphtheria toxoid
Tetanus toxoid
Polio virus type 1 inactivated
Polio virus type 2 inactivated
Polio virus type 3 inactivated
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/108/001

Group Information

ATC CodeJ07CA02 diphtheria-pertussis-poliomyelitis-tetanus

Status

License statusAuthorised
Licence Issued05/08/2005
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print